Skip to main content

Gengos Andrew's Form 4/A amendment

Amended

LeonaBio, Inc. (LONA) · filed Feb 16, 2024

Accession no.
0001415889-24-004149
Filed
Feb 16, 2024
Trade date
Jan 4-5, 2024
Filing delay
43 days
Rule 10b5-1 plan
Not checked
Original filed
Jan 8, 2024

This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.52K. It was filed 43 days after the trade.

This amendment replaces 0001209191-24-001153 (filed Jan 8, 2024).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gengos AndrewCIK 0001563623Officer (CFO AND CHIEF BUSINESS OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 4, 2024Common StockAGrant or awardAcquired+5,000$0.00$085,012Direct
Jan 5, 2024Common StockSSaleDisposed−1,208$2.91−$3,515.2883,804Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)